Christopher Brittain
Impact in
- Ophthalmology top 0.2%
- Retinal Diseases and Treatments
- Glaucoma and retinal disorders
- Retinal and Optic Conditions
-
- Retinal Imaging and Analysis
Papers in
-
- Retinal Diseases and Treatments 14
- Retinal and Optic Conditions 4
- Glaucoma and retinal disorders 2
-
- Retinal Imaging and Analysis 4
- Co-authors
- Erin C. Henry (3 shared papers)Srinivas R. Sadda (4 shared papers)Daniela Ferrara (4 shared papers)Frank G. Holz (3 shared papers)Paul Mitchell (2 shared papers)Monika Fleckenstein (1 shared paper)K. Bailey Freund (1 shared paper)Menno van Lookeren Campagne (1 shared paper)
- Journals
- Ophthalmology (6 papers)Investigative Ophthalmology & Visual Science (3 papers)Eye (2 papers)Retina (2 papers)Ophthalmology Retina (2 papers)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
Christopher Brittain
22 papers receiving 1.5k citations
Christopher Brittain's Hit Papers
Peers
Comparison fields: 5 of 73
- Ophthalmology 1.1k
- Radiology, Nuclear Medicine and Imaging 390
- Complementary and alternative medicine 88
- Orthopedics and Sports Medicine 59
- Immunology 85
Countries citing papers authored by Christopher Brittain
This map shows the geographic impact of Christopher Brittain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Brittain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Brittain more than expected).
Fields of papers citing papers by Christopher Brittain
This network shows the impact of papers produced by Christopher Brittain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Brittain. The network helps show where Christopher Brittain may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Brittain, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration Hit paper breakdown → | 2017 | 395 |
| 2 | Efficacy and Safety of Lampalizumab for Geographic Atrophy Due to Age-Related Macular Degeneration Hit paper breakdown → | 2018 | 269 |
| 3 | 2016 | 188 | |
| 4 | Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration Hit paper breakdown → | 2021 | 125 |
| 5 | 2016 | 104 | |
| 6 | 2001 | 92 | |
| 7 | 2018 | 88 | |
| 8 | 2013 | 76 | |
| 9 | 2020 | 48 | |
| 10 | 2020 | 47 | |
| 11 | Efficacy and Safety of Faricimab for Macular Edema due to Retinal Vein Occlusion Hit paper breakdown → | 2024 | 38 |
| 12 | 2013 | 38 | |
| 13 | 2015 | 37 | |
| 14 | 2006 | 9 | |
| 15 | 2019 | 6 | |
| 16 | Faricimab in Neovascular Age-Related Macular Degeneration: 1-Year Efficacy, Safety, and Durability in the Phase 3 TENAYA and LUCERNE Trials | 2021 | 5 |
| 17 | 2007 | 5 | |
| 18 | 2024 | 4 | |
| 19 | Lampalizumab for geographic atrophy (GA) in age-related macular degeneration (AMD): pooled results of the Chroma and Spectri phase 3 randomized clinical trials (RCTs) | 2018 | 2 |
| 20 | Initial lesion growth rates and other baseline prognostic factors can improve the design of clinical trials in Geographic Atrophy (GA) | 2020 | 2 |
About Christopher Brittain
Christopher Brittain is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Pathology and Forensic Medicine and Cardiology and Cardiovascular Medicine, having authored 23 papers that have together received 1.6k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (14 papers), Retinal Imaging and Analysis (4 papers), Retinal and Optic Conditions (4 papers), Ophthalmology and Eye Disorders (2 papers), Glaucoma and retinal disorders (2 papers), Cardiovascular and exercise physiology (1 paper), Remote Sensing in Agriculture (1 paper) and Cardiovascular Effects of Exercise (1 paper). The work is most often cited by research in Ophthalmology (1.1k citations), Radiology, Nuclear Medicine and Imaging (390 citations), Complementary and alternative medicine (88 citations), Orthopedics and Sports Medicine (59 citations) and Immunology (85 citations). Christopher Brittain has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Erin C. Henry, Srinivas R. Sadda, Daniela Ferrara, Frank G. Holz, Paul Mitchell, Monika Fleckenstein, K. Bailey Freund, Menno van Lookeren Campagne, David S. Boyer and Ursula Schmidt‐Erfurth. Their work appears in journals such as Ophthalmology, Investigative Ophthalmology & Visual Science, Eye, Retina and Ophthalmology Retina.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.